SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2230)2/8/2008 11:06:52 AM
From: Jibacoa  Respond to of 3722
 
VNUS made a 3Yrs H after opening with a good UG.The stock was up 27.88% at its intraday H & still is up 20.95% with volume of 326,835 close to 5x its ADV.

bigcharts.marketwatch.com

It announced yesterday its 4thQ results.The revenues increased 54% to $20.6M vs. $13.3M in 2006. The income was $0.9M vs. a loss of $2.0M in 2006.For the full Yr. the earnings were $0.05/shr vs. a loss of $0.36/shr in 2006.(It had reported losses in the first 3Qs, in spite of double digit improvement on revenues, but the loss had been trimmed some in the 3rdQ.<g>

It reported $63.3M in cash, which was $0.6M < than in the 3rdQ.

The stock needs to close above its Nov 2004 H of $21.30 in order to make an all time H.

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2230)2/26/2008 3:14:33 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
NRMX has been up 19.7% & is still up 13.87% on volume of 218,162 which is > its ADV

bigcharts.marketwatch.com

As previously mentioned, NRMX has been able to trim some its losses in the last 2Qs in spite of lower revenues.

The stock has a good amount of resistance at the $2 level.The "analysts" have a target around $2.50. With some good news & better market environment it seems the stock could double from present levels.<g>

bigcharts.marketwatch.com

Bernard